This startup operates as a contract development and manufacturing organization, providing services such as injectable drug formulation development, analytical method development, and process scale-up for biopharmaceutical partners. By offering formulation and filling of vials, syringes, and cartridges, the company enables faster production of medications to meet clinical and commercial demands in the healthcare industry.
Funding
$86.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Biopharmaceutical companies often face challenges in efficiently scaling up production and meeting the stringent quality requirements for injectable drugs, leading to delays in clinical trials and commercialization. Managing complex supply chains and navigating regulatory hurdles further complicates the process of bringing life-saving medications to market.
Solution
INCOG BioPharma Services is a contract development and manufacturing organization (CDMO) that provides comprehensive, end-to-end solutions for sterile injectable drug products, spanning clinical through commercial phases. The company's FDA-approved and Annex 1-compliant facility utilizes advanced barrier isolation filling technology and high-speed filling equipment to manufacture high-value biologics and peptides. INCOG offers tailored manufacturing solutions, filling into vials, syringes, and cartridges, while also providing autoinjector assembly, final packaging, and in-house analytical services. By streamlining the manufacturing process and simplifying complex supply chains, INCOG enables biopharmaceutical partners to accelerate drug development and focus on advancing their therapies.
Target Audience
INCOG BioPharma Services primarily serves biopharmaceutical companies developing sterile injectable drugs, from early-stage clinical trials to commercial manufacturing.
Features
- Formulation, analytical method, and process development
- QC chemistry and microbiology testing
- Barrier isolation filling technology
- Time pressure or peristaltic pump filling mechanism
- Non-destructive weight verification inline
- Zero glass-to-glass contact for syringes & cartridges
- Vial filling: 2R
- 30R (ready to use or bulk)
- Syringe filling: 0.5 mL, 1mL Long, 1-3mL, 5mL, 10mL (ready to use)
- Cartridge filling: 1.5mL, 2mL, 3mL (ready to use)
- Inspection, labeling, and packaging
- Device assembly
- Material and finished product storage